A rapid, high-expression stable cell line development platform that supports fast, platform-based cell culture process development. Zencore can complete construction from protein sequence to monoclonal cell line in just 3 months.
A triple advantage of timeline, throughput and compliance, creating a fast track from sequence to high-yield stable cell line.
Monoclonal screening begins as early as the Isolate stage, progressively locking in TOP clones, with monoclonal RCB delivered in 3 months.
Historical platform data for mAbs, bispecifics and recombinant proteins, with stable titers and batch-to-batch consistency.
Horizontal bars drawn to a uniform scale (full bar = 15.0 g/L) - data from historical Zencore platform projects
Multiple host platforms available with complete compliance documentation, supporting global filing and launch.
the hardware cornerstone for high-throughput monoclonal screening and imaging traceability.
Efficient single-cell printing and sorting with an effective monoclonality rate of up to 90%
Continuous imaging of culture plates to monitor monoclonal growth and division throughout
BLI assays replace conventional ELISA, greatly improving screening throughput and accuracy
Monoclonal antibody, bispecific or recombinant protein? Zencore's cell line development platform moves your project rapidly into process and manufacturing stages.
Inquire about cell line development